Epitalón
Tetrapeptide (Ala-Glu-Asp-Gly)
Tetrapeptide with longevity hypotheses and very limited evidence.
Back to technical sheets- Class
- Tetrapeptide (Ala-Glu-Asp-Gly)
- Also known as
- Research compound; longevity claims unconfirmed
Mechanism of action
It is proposed to modulate telomerase activity and pineal/melatonin function. Data are limited and come mostly from a small number of research groups.
Evidence
Preclinical
Preclinical and small studies of low methodological quality. Longevity claims are not confirmed by robust trials. Not approved.
Studied uses
- None approved (longevity hypotheses under study)
Safety considerations
- Very limited, low-quality evidence
- No robust trials supporting the claims
- Not approved for human use
Batch quality data
We publish these figures because they are the ones the program itself teaches you to ask for.
- Presentation
- Polvo liofilizado en vial sellado
50 mg Coming soon
Educational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.